The caspase inhibitor z-VAD is more effective than CD18 adhesion blockade in reducing muscle ischemia-reperfusion injury: implication for clinical trials (Q44117636)

From Wikidata
Jump to navigation Jump to search
scientific article published in September 2002
edit
Language Label Description Also known as
English
The caspase inhibitor z-VAD is more effective than CD18 adhesion blockade in reducing muscle ischemia-reperfusion injury: implication for clinical trials
scientific article published in September 2002

    Statements

    The caspase inhibitor z-VAD is more effective than CD18 adhesion blockade in reducing muscle ischemia-reperfusion injury: implication for clinical trials (English)
    Akiko Iwata
    John M Harlan
    Nicholas B Vedder
    Robert K Winn
    1 September 2002
    2077-2080

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit